회사 개요
Quaker Chemical Corporation, which operates under the trade name Quaker Houghton, specializes in the development, production, and marketing of formulated specialty chemical products alongside chemical management services tailored for heavy industrial and manufacturing applications. The corporation functions within the Basic Materials sector and specifically targets the Specialty Chemicals industry, positioning itself as a provider of industrial process fluids on a global scale. This entity employs a workforce of 4,700 individuals and maintains a total market capitalization of $2.26B, reflecting its established presence in the specialty chemical market. With annual revenue reaching $1.89B, these financial figures indicate that the company operates with a substantial economic footprint, serving a wide array of industrial clients worldwide.
재무 건전성
The company reported a trailing twelve-month revenue of $1.89B, while net income for the same period stood at -$2,468,000, and EBITDA was recorded at $286.79M, highlighting a significant divergence between top-line performance and bottom-line profitability. The substantial gap between the high revenue figure and the negligible net income reveals a cost structure where operating expenses and other deductions effectively erase most of the gross profit, resulting in a negative profit margin. Despite the net loss, the entity generated free cash flow of $91.07M, which provides a degree of financial flexibility by allowing the company to meet operational obligations or fund investments without relying solely on external financing. The gross margin stands at 36.3%, indicating that the company retains more than a third of revenue as gross profit before accounting for operating expenses, while the operating margin is 9.0%, suggesting that overhead costs consume a significant portion of that gross profit. The profit margin is -0.1%, confirming that the company is currently unprofitable on a net basis. In terms of leverage, the company holds $179.84M in cash against $905.85M in total debt, resulting in a debt-to-equity ratio of 65.81, which characterizes the balance sheet as highly leveraged relative to its equity base. The current ratio is 2.42, a metric that indicates the company possesses more than double the current assets necessary to cover its short-term liabilities, suggesting adequate short-term liquidity. Return on Equity is -0.2%, reflecting the negative impact of the net loss on shareholder equity, whereas Return on Assets is 4.5%, implying that the company's assets are generating positive earnings before interest and taxes despite the net loss position.
밸류에이션 평가
Valuation metrics present a mixed picture, with the forward P/E ratio at 13.99 compared to a trailing P/E ratio listed as N/A, which implies that analysts are projecting normalized earnings in the future to overcome current losses. The price-to-book ratio is 1.65, suggesting that the market values the company's equity at a premium of 65% over its book value, potentially reflecting confidence in the intangible assets or future earnings potential of the specialty chemical portfolio. Alternative valuation metrics such as the price-to-sales ratio of 1.20 and an EV/EBITDA of 10.42 offer different perspectives, indicating that investors are willing to pay a price equivalent to 1.20 times annual sales or 10.42 times the unlevered earnings. The stock has traded between a 52-week low of $95.91 and a 52-week high of $183.01, placing the current trading price within a volatile range that demonstrates significant price discovery over the last year. With a beta of 1.42, the stock exhibits price volatility that is 42% higher than the broader market, indicating that the share price is likely to move more sharply than the S&P 500 during periods of market fluctuation.
Growth & Income
The company demonstrated a revenue growth rate of 5.5% year-over-year, while earnings growth was recorded at 48.6%, indicating that earnings are recovering at a much faster pace than revenue due to the normalization of the previously reported net loss. As a dividend payer, the corporation offers a dividend yield of 1.6% with a payout ratio of 35.6%, which suggests that the dividend is being funded from cash flow rather than net income, raising considerations regarding long-term sustainability given the current negative net income position. The earnings growth figure of 48.6% contrasts sharply with the 5.5% revenue growth, implying that improvements in cost management or the resolution of one-time charges are driving profitability faster than top-line expansion. Overall, the growth and income profile presents a company that is expanding its sales base while aggressively returning cash to shareholders, though the negative net income warrants close monitoring of the path to sustained profitability.